Orthofix Selling And Marketing Expenses from 2010 to 2024

OFIX Stock  USD 19.53  0.40  2.09%   
Orthofix Medical Selling And Marketing Expenses yearly trend continues to be fairly stable with very little volatility. Selling And Marketing Expenses will likely drop to about 198.7 M in 2024. During the period from 2010 to 2024, Orthofix Medical Selling And Marketing Expenses regression line of annual values had r-squared of  0.36 and arithmetic mean of  200,203,323. View All Fundamentals
 
Selling And Marketing Expenses  
First Reported
2006-03-31
Previous Quarter
100.2 M
Current Value
96.6 M
Quarterly Volatility
24 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Orthofix Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Orthofix Medical's main balance sheet or income statement drivers, such as Interest Expense of 9.1 M, Total Revenue of 784 M or Gross Profit of 259.2 M, as well as many indicators such as Price To Sales Ratio of 0.63, Dividend Yield of 0.0 or PTB Ratio of 0.79. Orthofix financial statements analysis is a perfect complement when working with Orthofix Medical Valuation or Volatility modules.
  
Check out the analysis of Orthofix Medical Correlation against competitors.
For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.

Latest Orthofix Medical's Selling And Marketing Expenses Growth Pattern

Below is the plot of the Selling And Marketing Expenses of Orthofix Medical over the last few years. It is Orthofix Medical's Selling And Marketing Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Orthofix Medical's overall financial position and show how it may be relating to other accounts over time.
Selling And Marketing Expenses10 Years Trend
Slightly volatile
   Selling And Marketing Expenses   
       Timeline  

Orthofix Selling And Marketing Expenses Regression Statistics

Arithmetic Mean200,203,323
Geometric Mean118,563,509
Coefficient Of Variation37.76
Mean Deviation40,243,523
Median200,343,000
Standard Deviation75,597,026
Sample Variance5714.9T
Range385.7M
R-Value0.60
Mean Square Error3917.3T
R-Squared0.36
Significance0.02
Slope10,191,789
Total Sum of Squares80008.7T

Orthofix Selling And Marketing Expenses History

2024198.7 M
2023385.7 M
2022228.8 M
2021221.3 M
2020204.4 M
2019223.7 M
2018205.5 M

About Orthofix Medical Financial Statements

Orthofix Medical investors use historical fundamental indicators, such as Orthofix Medical's Selling And Marketing Expenses, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Orthofix Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Selling And Marketing Expenses385.7 M198.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Orthofix Stock Analysis

When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.